STABILITY OF CISPLATIN, IPROPLATIN, CARBOPLATIN, AND TETRAPLATIN IN COMMONLY USED INTRAVENOUS SOLUTIONS

被引：59

作者：

CHEUNG, YW

CRADOCK, JC

VISHNUVAJJALA, BR

FLORA, KP

机构：

[1] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,PHARMACEUT RES BRANCH,BLDG 37,ROOM 6D12,BETHESDA,MD 20892

[2] NCI,ANALYT & PROD DEV SECT,BETHESDA,MD 20892

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1987年 / 44卷 / 01期

关键词：

D O I：

10.1093/ajhp/44.1.124

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：124 / 130

页数：7

共 24 条

[11] REACTION OF CIS-PLATINUM WITH SODIUM BISULFITE
HUSSAIN, AA
HADDADIN, M
IGA, K
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (03) : 364 - 365
[12] TRACE ANALYSIS FOR CIS-PLATINUM ANTI-CANCER DRUGS VIA LCEC
KRULL, IS
DING, XD
BRAVERMAN, S
SELAVKA, C
HOCHBERG, F
STERNSON, LA
[J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1983, 21 (04) : 166 - 173
[13] NEW PLATINUM COMPLEXES IN CLINICAL-TRIALS
LEE, FH
CANETTA, R
ISSELL, BF
LENAZ, L
[J]. CANCER TREATMENT REVIEWS, 1983, 10 (01) : 39 - 51
[14] PRECLINICAL STUDIES ON TOXICITY, ANTITUMOUR ACTIVITY AND PHARMACOKINETICS OF CISPLATIN AND 3 RECENTLY DEVELOPED DERIVATIVES
LELIEVELD, P
VANDERVIJGH, WJF
VELDHUIZEN, RW
VANVELZEN, D
VANPUTTEN, LM
ATASSI, G
DANGUY, A
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08): : 1087 - 1104
[15] CISPLATIN - CHEMISTRY, DISTRIBUTION AND BIOTRANSFORMATION
LONG, DF
REPTA, AJ
[J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (01) : 1 - 16
[16] MARIANI EP, 1980, CISPLATIN CURRENT ST, P305
[17] PLATINUM COMPOUNDS - A NEW CLASS OF POTENT ANTITUMOUR AGENTS
ROSENBERG, B
VANCAMP, L
TROSKO, JE
MANSOUR, VH
[J]. NATURE, 1969, 222 (5191) : 385 - +
[18] SEGAL E, 1985, CANCER RES, V45, P492
[19] SMITH IE, 1985, CANCER TREAT REP, V69, P43
[20] STARK JJ, 1977, CLIN RES, V25, pA412